Search Results for: TTPH

Top Analyst Upgrades and Downgrades: Chipotle, Delphi, Dollar General, Facebook, Ingersoll-Rand, Nike, Okta, Quest Diagnostics and More

The futures were trading slightly lower Monday morning as investors hoped for another solid week of gains from the stock market. With the NCAA Men's Basketball Tournament starting on Thursday, ...
Read Full Story »

Tetraphase Prepares for US Launch of Xerava

Tetraphase Pharmaceuticals Inc. (NASDAQ: TTPH) shares were up handily on Friday after the company announced the U.S. commercial launch of Xerava (eravacycline) for the treatment of complicated intra-abdominal infections (cIAI). ...
Read Full Story »

Why Tetraphase Pharmaceuticals Shares Are Popping

Shares of Tetraphase Pharmaceuticals Inc. (NASDAQ: TTPH) saw a solid gain early Wednesday after the company announced an exclusive licensing agreement in Asia. Specifically, the firm announced that it has ...
Read Full Story »

Eldorado Gold, Teekay Tankers Dip into Tuesday’s 52-Week Low Club

February 20, 2018: Here are four stocks trading with heavy volume among 45 equities making new 52-week lows in Tuesday's session. On the NYSE decliners led advancers by about 2 ...
Read Full Story »

Treehouse Foods, Baker Hughes Sink into Thursday’s 52-Week Low Club

February 15, 2018: Here are four stocks trading with heavy volume among 51 equities making new 52-week lows in Thursday's session. On the NYSE advancers led decliners by 2 to ...
Read Full Story »

Tetraphase Pharma, Tanger Dive into Wednesday’s 52-Week Low Club

February 14, 2018: Here are four stocks trading with heavy volume among 81 equities making new 52-week lows in Wednesday's session. On the NYSE advancers led decliners by more than ...
Read Full Story »

Why Tetraphase Pharmaceuticals Is Getting Cut in Half

Tetraphase Pharmaceuticals Inc. (NASDAQ: TTPH) saw its shares get cut in half on Wednesday after the firm provided an update on its late-stage clinical trial for the treatment of complicated ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Avis Budget, Blue Apron, Chipotle, Domino’s, Northrop Grumman, Pepsi, Rio Tinto, T-Mobile, Valero and More

Volatility is back, with another day of gains rapidly turning into strong selling pressure with consumer prices indicating hotter than expected inflation. Some signals were already pointing to this, but ...
Read Full Story »

Top Analyst Upgrades and Downgrades: American Express, Cisco, First Solar, Goldman Sachs, Nasdaq, Shopify, SunPower, Workday and More

Monday's early equity market indications were for a higher open with the Dow Jones industrial average indicated over 250 points higher and the S&P 500 indicated up more than 25 ...
Read Full Story »

Top Analyst Upgrades and Downgrades: CalAmp, Fiat Chrysler, Lowe’s, Plains All American, Ulta Beauty and Many More

Stocks were indicated to open higher on Monday and the major indexes remain close to all-time highs. Energy stocks and insurers are expected to be volatile after Hurricane Harvey (now a ...
Read Full Story »

Tetraphase Pharma Decides to Reap Profits With Secondary Offering

Tetraphase Pharmaceuticals Inc. (NASDAQ: TTPH) saw its shares pull back on Friday after the company announced that it has priced a secondary offering. Keep in mind that even though shares ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Agilent, Apple, Citigroup, Exxon, M&T Bank, Snap, Toyota, Twitter and Many More

Stocks were marginally lower on Tuesday morning, but the major indexes all remain within striking distance of their all-time highs. Now that the bull market is over eight years old, ...
Read Full Story »

5 Biotech Stocks That Could Skyrocket From Upcoming Catalysts

Needless to say, the biotech world has had a very difficult 18 months. Even the biggest and the best companies, many of which trade cheaper than big pharmaceutical companies, have ...
Read Full Story »
biotech word cloud

4 Key FDA Decisions Expected By Year End

Pharmaceutical companies generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk to a great amount ...
Read Full Story »
3d life ring

How the Technology of One Small Biotech Can Save Tetraphase

Tetraphase Pharmaceuticals Inc. (NASDAQ: TTPH) continues to reel from the spectacular and unexpected failure of its flagship candidate, eravacycline. Shares have essentially reverted to IPO level and lost almost all ...
Read Full Story »